These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 4994886

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Myelodepressive effect during intracavitary cytostatic treatment of bladder tumors].
    González R, Millones A, Guzmán A, Gelabert A.
    Arch Esp Urol; 1979; 32(1):49-52. PubMed ID: 109052
    [Abstract] [Full Text] [Related]

  • 23. The value of thiotepa in the treatment of superficial bladder tumors.
    Akdaş A, Kirkali Z, Sengör F, Ilker Y, Taşar C.
    Turk J Pediatr; 1984; 26(1-4):243-50. PubMed ID: 6443167
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Cell kinetics of the bladder carcinoma. III. Changes of the cell cycle following thio-TEPA treatment and possible factors for kinetics of cell killing in cultured human bladder carcinoma cells (author's transl)].
    Kato T, Ishikawa K, Nemoto R.
    Nihon Hinyokika Gakkai Zasshi; 1977 Nov; 68(11):1029-35. PubMed ID: 415167
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Fatal bone marrow aplasia due to endovesical thio-tepa].
    Navas P, Grasset D.
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):489-91. PubMed ID: 4216649
    [No Abstract] [Full Text] [Related]

  • 29. [Spontaneously cured pancytopenia due to intravesical thio-tepa, apropos of one case].
    Archimbaud JP, Calcat P, Martel JP.
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):487-8. PubMed ID: 4216648
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW, Prout GR, Smith W, Frable WJ, Minnis JE.
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract] [Full Text] [Related]

  • 36. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT, Daly JJ, Heaney JA, Heney NM, Prout GR.
    J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
    [Abstract] [Full Text] [Related]

  • 37. Intravesical treatment with thiotepa: an update review.
    Fosså SD.
    Prog Clin Biol Res; 1984 Jan; 162B():163-8. PubMed ID: 6438640
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The effect of the drug thio-TEPA on the microbial flora of the urine of patients with urinary bladder neoplasms].
    Stetsenko DV.
    Klin Khir (1962); 1972 Oct; 10():82. PubMed ID: 4633206
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.